a deal with big pharma is just selling off the farm or part of it to then have enough cash to sell a drug or 3. So it’s not really the biggest catalyst. The biggest catalyst in my view is efficacy, ( say half) and then drug approval …. And then that validates the platform. Worth another 3x those 2 combined. It’s just a matter of who values what when, but 4BUS for4 4 drugs in clinic is not a stretch at all. That’s 60x our mcap as of today.
PYC timelines to revenue, page-9
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.3¢ | 12.0¢ | $624.5K | 5.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1227634 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 130000 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |